Vancouver, British Columbia – TheNewswire – September 13, 2019 – Naturally Splendid Enterprises Ltd. (“Naturally Splendid” or “the Company”) (FRANKFURT:50N) (TSXV:NSP) (OTC:NSPDF) is pleased to announce that, subject to regulatory approval, the Company intends to amend the term of certain previously issued share purchase warrants.
In connection with a private placement that the Company completed on October 16, 2017, 927,321 share purchase warrants (the “Warrants”) were issued with an exercise price of $0.27 per share and an expiry date of October 16, 2019. The Company intends to file an application with the TSX Venture Exchange to extend the term for exercising the Warrants by two additional years to October 16, 2021 with the exercise price of $0.27 per share remaining unchanged.
In connection with a private placement that the Company completed on October 13, 2017, 178,571 share purchase warrants (the “Warrants”) were issued with an exercise price of $0.22 per share and an expiry date of October 13, 2019. The Company intends to file an application with the TSX Venture Exchange to extend the term for exercising the Warrants by two additional years to October 13, 2021 with the exercise price of $0.22 per share remaining unchanged.
In connection with a private placement that the Company completed on November 1, 2017, 190,404 share purchase warrants (the “Warrants”) were issued with an exercise price of $0.22 per share and an expiry date of November 1, 2019. The Company intends to file an application with the TSX Venture Exchange to extend the term for exercising the Warrants by two additional years to November 1, 2021 with the exercise price of $0.22 per share remaining unchanged.
About Naturally Splendid Enterprises Ltd.
Naturally Splendid is a biotechnology and consumer products company that is developing, producing, commercializing, and licensing an entirely new generation of plant-derived, bioactive ingredients, nutrient-dense foods, and related products. Naturally Splendid is focused on the commercial uses of industrial hemp, and once regulations allow, in permitting jurisdictions, this will include CBD (cannabidiol), and other cannabinoid compounds in a broad spectrum of applications.
For more information e-mail [email protected] or call Investor Relations at 604-673-9573
On Behalf of the Board of Directors
Mr. Craig Goodwin
CEO, President, Director
Contact Information
Naturally Splendid Enterprises Ltd.
(NSP – TSX Venture; NSPDF – OTCQB; 50N Frankfurt)
#108-19100 Airport Way
Pitt Meadows, BC, V3Y 0E2
Office: (604) 465-0548
Fax: (604) 465-1128
E-mail: [email protected]
Website: www.naturallysplendid.com
Forward-Looking Statements
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid’s control including, Naturally Splendid’s ability to compete with large food and beverage companies; sales of any potential products developed will be profitable; sales of shelled hemp seed will continue at existing rates or increase; customers will complete on sales contracts; and the risk that any of the potential applications may not receive all required regulatory or legal approval. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information.
NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
